RE: Hi all2 Aug 2018 11:17
There are two parts of the marketing of Fruitflow, the patented heart health product which Provexis owns the IP for.
DSM has an Alliance Agreement which allows them to produce and market Fruitflow over the entire world. All holders have known since 2010 that the work of DSM is conducted on a confidential manner. Therefore demands for details are misleading, just a feeble attempt to cause aggro. The agitators have to keep reinventing their ID's fairly often, for what purpose we can only guess.
Provexis Retail is selling Fruitflow directly, launched in 2016 as Fruitflow+Omega3 from its own website Fruitflowplus.com. They have now agreed with Holland and Barrett to launch this product through their retail shops and to their extensive online database. Staff are to be trained in the health benefits of Fruitflow. Stock has been ordered, and is expected this month.
Provexis Retail also intend to add Fruitflow + NO to the range, though launch date hasn't yet been fixed.
Successive updates state that DSM are involved in a growing pipeline of future Fruitflow products, without being specific on any detail, for the aforementioned reasons.
Further funding may be needed, the consensus appears to be that it will, depending on several variables regarding revenue inflows, and marketing and admin out flows. The next update is due fairly soon, this will throw more light on this. The last fundings have been well supported by main investors and PI's.